Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • TROP2
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
Filter
Search Result
Results for "

immu 132

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Sacituzumab govitecan
    IMMU-132
    T778241491917-83-9
    Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
    • $455
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot